VitaLink acquires Comprehensive Clinical Trials
VitaLink Research (VLR) today announced its acquisition of Comprehensive Clinical Trials (CCT).
Founded in 2004, VLR has 13 locations in the US. According to the company, headquartered in Greenville, SC, the addition expands its reach throughout the Southeast.
“The partnership with Comprehensive Clinical Trials is a critical milestone in the company’s expansion into the growing field of women’s health,” said Nick Wright, CEO of VitaLink Research, in a statement.
Dr. Ronald Ackerman, founder of CCT, will continue to lead the CCT business. Said Ackerman, “The strong infrastructure that VitaLink has established will enable CCT to focus exclusively on clinical research and expanding our women’s health expertise throughout the VitaLink network.”
VTL is owned by the health care investment firm, Great Point Partners (GPP), based in Greenwich, CT. The company has approximately $1bn of equity capital under management.
